Literature DB >> 24173329

Appendix B: clinical examples.

.   

Abstract

Year:  2010        PMID： 24173329     DOI： 10.1093/jicru/ndq012

Source DB:  PubMed          Journal:  J ICRU        ISSN： 1473-6691


× No keyword cloud information.
  7 in total

1.  Recommendations of the Spanish Societies of Radiation Oncology (SEOR), Nuclear Medicine & Molecular Imaging (SEMNiM), and Medical Physics (SEFM) on (18)F-FDG PET-CT for radiotherapy treatment planning.

Authors:  Begoña Caballero Perea; Antonio Cabrera Villegas; José Miguel Delgado Rodríguez; María José García Velloso; Ana María García Vicente; Carlos Huerga Cabrerizo; Rosa Morera López; Luis Alberto Pérez Romasanta; Moisés Sáez Beltrán
Journal:  Rep Pract Oncol Radiother       Date:  2012-11-17

2.  Parotid glands in whole-brain radiotherapy: 2D versus 3D technique for no sparing or sparing.

Authors:  Marianna Trignani; Domenico Genovesi; Annamaria Vinciguerra; Angelo Di Pilla; Antonietta Augurio; Monica Di Tommaso; Giampiero Ausili Cèfaro; Marta Di Nicola
Journal:  Radiol Med       Date:  2014-07-18       Impact factor: 3.469

3.  Dosimetric Comparison of Three-Dimensional Conformal Radiotherapy (3D-CRT) and Intensity Modulated Radiotherapy Techniques (IMRT) with Radiotherapy Dose Simulations for Left-Sided Mastectomy Patients.

Authors:  Serhat Aras; Türkan İkizceli; Meryem Aktan
Journal:  Eur J Breast Health       Date:  2019-04-01

4.  Benchmarking a commercial proton therapy solution: The Paul Scherrer Institut experience.

Authors:  Sara Rosas; Francesca M Belosi; Nicola Bizzocchi; Till Böhlen; Stefan Zepter; Petra Morach; Antony J Lomax; Damien C Weber; Jan Hrbacek
Journal:  Br J Radiol       Date:  2020-01-30       Impact factor: 3.039

5.  Pre-treatment 2D and 3D dosimetric verification of volumetric arc therapy. A correlation study between gamma index passing rate and clinical dose volume histogram.

Authors:  Lukasz Szczurek; Robert Juszkat; Jolanta Szczurek; Ilona Turek; Piotr Sosnowski
Journal:  PLoS One       Date:  2019-08-13       Impact factor: 3.240

6.  A prospective study investigating the efficacy and toxicity of definitive ChemoRadiation and ImmunOtherapy (CRIO) in locally and/or regionally advanced unresectable cutaneous squamous cell carcinoma.

Authors:  Charles Lin; Trishna Ballah; Michelle Nottage; Karen Hay; Benjamin Chua; Lizbeth Kenny; Paul Thomas; Michele Teng; Jacqui Keller; Trang Le; Jennifer Edmunds; Brett Hughes
Journal:  Radiat Oncol       Date:  2021-04-09       Impact factor: 3.481

7.  Pretreatment hemoglobin level as a prognostic factor in patients with locally advanced head and neck squamous cell carcinoma.

Authors:  Cecília Melo-Alvim; Patrícia Miguel-Semedo; Rita Silva Paiva; Soraia Lobo-Martins; Helena Luna-Pais; Ana Lúcia Costa; Ana Rita Santos; André Florindo; Ana Luísa Vasconcelos; André N Abrunhosa-Branquinho; Paulo Palmela; Leonor Fernandes; Dolores Lopez Presa; Luís Costa; Leonor Ribeiro
Journal:  Rep Pract Oncol Radiother       Date:  2020-07-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.